RSC Advances · 2016 · 18 citations · 51 references
PharmacyMedicinal ChemistryOncologyApoptosisDrug DesignMolecular OncologyCytotoxic ChemotherapyLigand BindingTargeted Cancer TherapyApoptosis TargetingCancer Targeting LigandsSequence-selective CleavageSequence-specific Dna Cleavage
Bis((1,4-dimethyl-9<italic>H</italic>-carbazol-3-yl)methyl)amine (DMCM) has been designed as a novel anti-cancer agent which is believed to have a sequence-specific groove binding interaction with DNA, leading to anticancer effects.
51